N1-Headache Overview

  • Year Founded
  • 2013

Year Founded

  • Status
  • Private

  • Employees
  • 19

Employees

  • Latest Deal Type
  • 2ndary - Private

N1-Headache General Information

Description

Developer of a digital health platform designed to practice personalized and evidence-based medicine. The company offers clinical-grade, personalized disease management tools for people with a history of migraine, enabling medical professionals to understand the migraine attack patterns, and what may affect these, in an individualized manner.

Contact Information

Website
www.n1-headache.com
Ownership Status
Privately Held (backing)
Financing Status
Formerly Angel backed
Corporate Office
  • 1 Broadway
  • 14th Floor
  • Cambridge, MA 02142
  • United States
Primary Industry
Other Healthcare Technology Systems
Vertical(s)
LOHAS & Wellness, Digital Health, TMT, HealthTech, Life Sciences
Corporate Office
  • 1 Broadway
  • 14th Floor
  • Cambridge, MA 02142
  • United States

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

N1-Headache Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Secondary Transaction - Private Completed Generating Revenue
1. Angel (individual) Completed Generating Revenue
To view N1-Headache’s complete valuation and funding history, request access »

N1-Headache Patents

  • 44

    Total Documents Applications and Grants

  • Total Patents Families

  • 6

    Granted

  • Pending

  • Expiring in next 12 mo

N1-Headache Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20250167998-A1 Personal medical avatar Inactive 18-Feb-2022
WO-2023159236-A1 Personal medical avatar Inactive 18-Feb-2022
AU-2022386354-A1 Methods for determining a risk of medication overuse headache and alerting a user of medication overuse headache risk Inactive 12-Nov-2021
EP-4430624-A1 Methods for determining a risk of medication overuse headache and alerting a user of medication overuse headache risk Inactive 12-Nov-2021
EP-4430624-A4 Methods for determining a risk of medication overuse headache and alerting a user of medication overuse headache risk Inactive 12-Nov-2021 G16H20/10
To view N1-Headache’s complete patent history, request access »

N1-Headache Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Ready to get started?

Request a free trial

N1-Headache FAQs

  • When was N1-Headache founded?

    N1-Headache was founded in 2013.

  • Where is N1-Headache headquartered?

    N1-Headache is headquartered in Cambridge, MA.

  • What is the size of N1-Headache?

    N1-Headache has 19 total employees.

  • What industry is N1-Headache in?

    N1-Headache’s primary industry is Other Healthcare Technology Systems.

  • Is N1-Headache a private or public company?

    N1-Headache is a Private company.

  • What is N1-Headache’s current revenue?

    The current revenue for N1-Headache is .

  • How much funding has N1-Headache raised over time?

    N1-Headache has raised $1.5M.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process